Cereno Scientific presents positive topline results of Phase IIa trial with CS1 in PAH
30 Sep 2024CS1-003 Topline presentation
Cereno Scientific presents positive topline results of Phase IIa trial with lead candidate CS1 in Pulmonary Arterial Hypertension (PAH)
Tune in to hear more!
View the full slide deck presentation here (updated on page 44 in order to correct an error)